$19.120
-0.572 (-2.99%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ACAD por análisis de gráficos similares
Alphio's ACAD stock price prediction model matches the current Acadia Pharmaceuticals Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $19.10 (-0.11%). The 1-week path is $19.32 (+1.07%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Acadia Pharmaceuticals Inc.?
Given the current price of $19.12 and an RSI of 34.575, ACADIA Pharmaceuticals is not a strong buy at this moment. The stock has seen a significant decline of 29.94% over the past 20 days, indicating bearish momentum. While the gross margin remains high at 90.81%, the recent clinical trial setbacks and lowered analyst price targets suggest caution. The main risk is the potential for further declines if the company fails to regain investor confidence, especially as the stock is already down 27.27% year-to-date.
ACAD cerró en $19.12 el Friday, tras bajar -2.99%
Acadia Pharmaceuticals Inc. (ACAD) last closed at $19.12, losing -2.99%. These facts feed the 1-day and 1-week ACAD price prediction above.
Consenso de analistas
Acadia Pharmaceuticals Inc. (ACAD): 8 comprar, 2 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Acadia Pharmaceuticals Inc. (ACAD) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ACAD, ordenadas por similitud.
Análisis de estacionalidad de ACAD
Historically the probability of a positive October return for ACAD is 39.66%. August offers the highest probability of a positive month at 64.06%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ACAD
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $21.38 | $22.99 | $25.36 | +20.24% |
| Nov 2026 | $22.81 | $28.51 | $30.75 | +49.12% |
| Dec 2026 | $19.57 | $21.36 | $26.83 | +11.72% |
En 2026, se proyecta que Acadia Pharmaceuticals Inc. (ACAD) oscile entre $19.57 y $30.75.
Previsión mensual de Acadia Pharmaceuticals Inc. para 2026
En Oct de 2026, se proyecta que Acadia Pharmaceuticals Inc. promedie $22.99, con un mínimo de $21.38 y un máximo de $25.36.
En Nov de 2026, se proyecta que Acadia Pharmaceuticals Inc. promedie $28.51, con un mínimo de $22.81 y un máximo de $30.75.
En Dec de 2026, se proyecta que Acadia Pharmaceuticals Inc. promedie $21.36, con un mínimo de $19.57 y un máximo de $26.83.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.